Last reviewed · How we verify
NCT06108700
Ergonomic Risk Assessment for Musculoskeletal Disorders in Office Workers Turkish Version, Validity and Reliability Study
trial in Healthy in 120 participants. Completed in 30 December 2023.
30 November 2023
Quick facts
| Lead sponsor | Tokat Gaziosmanpasa University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 25 October 2023 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Tokat Gaziosmanpasa University
Who can join
Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Today, there is a relationship between the increase in the use of electronic devices such as smartphones or tablets and musculoskeletal disorders. Different usage styles of various electronic devices such as laptops, smartphones and tablets affect the risk factors that may be related to musculoskeletal disorders in office workers. In addition to the use of electronic devices, the posture of the office worker's head, waist and hands while sitting are among the risk factors. Parameters such as the features of the chair he is sitting on, the height and distance of the table affect the person's posture. Evaluation of these factors is important in preventing musculoskeletal disorders. The Ergonomic Risk Assessment for Musculoskeletal Disorders in Office Workers was developed by Kluay-On et al. in 2022 and its validity and reliability were established. The aim of our study is to culturally adapt the Ergonomic Risk Assessment for Musculoskeletal Disorders in Office Workers into Turkish and to examine its validity and reliability.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ergonomic risk assessment for musculoskeletal disorders in office workers Turkish version, validity and reliability study.
Erol E, Arıkan H. · · 2026 · PMID 42180615 · DOI 10.7717/peerj.21318
Verify or expand the search:
- PubMed search for NCT06108700
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Tokat Gaziosmanpasa University trials
Trials by the same sponsor.
- NCT07501988 — The Effect Of Color Rotation Technique Training On İnsülin Self-management İn Diabetic Patients. · NA · not yet recruiting
- NCT07154329 — Internet-Based EMDR Flash Intervention for Test Anxiety in University Students · NA · not yet recruiting
- NCT07340866 — Physical Fatigue, Compassion Fatigue, and Quiet Quitting in Physiotherapists · not yet recruiting
- NCT07351617 — Turkish Version of the Pain Metacognitions Questionnaire · not yet recruiting
- NCT07297784 — Impact of Problematic Media Use on Postoperative Pain in Children Undergoing Tonsillectomy · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06108700 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tokat Gaziosmanpasa University
- Last refreshed: 13 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06108700.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing